News
-
-
-
COMMUNIQUÉ DE PRESSE
TRIANA Biomedicines and Pfizer Enter Into A Research Collaboration to Discover Novel Molecular Glue Degraders for Multiple Disease Areas
TRIANA Biomedicines, Inc. partners with Pfizer for molecular glue discovery, receiving $49 million upfront payment and potential milestones. Collaboration to focus on oncology targets